Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of the Communities That HEAL Intervention on Overdose Education and Naloxone Distribution: A Cluster-Randomized, Wait-List Controlled Trial.
Freeman PR, Walley AY, Winhusen TJ, Oga EA, Villani J, Hunt T, Chandler RK, Oyler DR, Reilly B, Gelberg K, Douglas C, Lyons MS, Holloway J, Vandergrift NA, Adams JW, Asman K, Baker TJ, Brancato CJ, Cheng DM, Childerhose JE, David JL, Feaster DJ, Gilbert L, Glasgow LM, Goddard-Eckrich DA, Knott C, Knudsen HK, Lofwall MR, Marks KR, McMullan JT, Oser CB, Roberts MF, Shoben AB, Stein MD, Walters ST, Watson J, Zarkin GA, Jackson RD, Samet JH, Walsh SL, Bassel NE. Freeman PR, et al. Among authors: marks kr. Am J Public Health. 2025 Jan;115(1):83-94. doi: 10.2105/AJPH.2024.307845. Epub 2024 Oct 10. Am J Public Health. 2025. PMID: 39388670 Clinical Trial.
Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths.
HEALing Communities Study Consortium; Samet JH, El-Bassel N, Winhusen TJ, Jackson RD, Oga EA, Chandler RK, Villani J, Freisthler B, Adams J, Aldridge A, Angerame A, Babineau DC, Bagley SM, Baker TJ, Balvanz P, Barbosa C, Barocas J, Battaglia TA, Beard DD, Beers D, Blevins D, Bove N, Bridden C, Brown JL, Bush HM, Bush JL, Caldwell R, Calver K, Calvert D, Campbell ANC, Carpenter J, Caspar R, Chassler D, Chaya J, Cheng DM, Cunningham CO, Dasgupta A, David JL, Davis A, Dean T, Drainoni ML, Eggleston B, Fanucchi LC, Feaster DJ, Fernandez S, Figueroa W, Freedman DA, Freeman PR, Freiermuth CE, Friedlander E, Gelberg KH, Gibson EB, Gilbert L, Glasgow L, Goddard-Eckrich DA, Gomori S, Gruss DE, Gulley J, Gutnick D, Hall ME, Harger Dykes N, Hargrove SL, Harlow K, Harris A, Harris D, Helme DW, Holloway J, Hotchkiss J, Huang T, Huerta TR, Hunt T, Hyder A, Ingram VL, Ingram T, Kauffman E, Kimball JL, Kinnard EN, Knott C, Knudsen HK, Konstan MW, Kosakowski S, Larochelle MR, Leaver HM, LeBaron PA, Lefebvre RC, Levin FR, Lewis N, Lewis N, Lofwall MR, Lounsbury DW, Luster JE, Lyons MS, Mack A, Marks KR, Marquesano S, Mauk R, McAlearney AS, McConnell K, McGladrey ML, McMullan J, Miles J, Muno… See abstract for full author list ➔ HEALing Communities Study Consortium, et al. Among authors: marks kr. N Engl J Med. 2024 Sep 19;391(11):989-1001. doi: 10.1056/NEJMoa2401177. Epub 2024 Jun 16. N Engl J Med. 2024. PMID: 38884347 Clinical Trial.
Utilization of long-acting injectable monthly depot buprenorphine for opioid use disorder (OUD) in Kentucky, before and after COVID-19 related buprenorphine access policy changes.
Hammerslag LR, Talbert J, Slavova S, Lei F, Freeman PR, Marks KR, Fanucchi LC, Walsh SL, Lofwall MR. Hammerslag LR, et al. Among authors: marks kr. J Subst Use Addict Treat. 2024 Sep;164:209391. doi: 10.1016/j.josat.2024.209391. Epub 2024 May 11. J Subst Use Addict Treat. 2024. PMID: 38740189
Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trial.
Glasgow L, Douglas C, Sprunger JG, Campbell ANC, Chandler R, Dasgupta A, Holloway J, Marks KR, Roberts SM, Martinez LS, Thompson K, Weiss RD, Aldridge A, Asman K, Barbosa C, Blevins D, Chassler D, Cogan L, Fanucchi L, Hall ME, Hunt T, Jadovich E, Levin FR, Lincourt P, Lofwall MR, Loukas V, McAlearney AS, Nunes E, Oga E, Oller D, Rudorf M, Sullivan AM, Talbert J, Taylor A, Teater J, Vandergrift N, Woodlock K, Zarkin GA, Freisthler B, Samet JH, Walsh SL, El-Bassel N. Glasgow L, et al. Among authors: marks kr. Drug Alcohol Depend. 2024 Jun 1;259:111286. doi: 10.1016/j.drugalcdep.2024.111286. Epub 2024 Apr 5. Drug Alcohol Depend. 2024. PMID: 38626553 Clinical Trial.
Bystander preference for naloxone products: a field experiment.
Marks KR, Oyler DR, Strickland JC, Jaggers J, Roberts MF, Miracle DK, Barnes C, Lei F, Smith A, Mackin E, Martin MC, Freeman PR. Marks KR, et al. Harm Reduct J. 2023 Nov 28;20(1):171. doi: 10.1186/s12954-023-00904-9. Harm Reduct J. 2023. PMID: 38017424 Free PMC article.
Corrigendum to "Model and approach for assessing implementation context and fidelity in the HEALing Communities Study" [Drug Alcohol Depend. 217 (2020) 108330].
Knudsen HK, Drainoni ML, Gilbert L, Huerta TR, Oser CB, Aldrich AM, Campbell ANC, Crable EL, Garner BR, Glasgow LM, Goddard-Eckrich D, Marks KR, McAlearney AS, Oga EA, Scalise AL, Walker DM. Knudsen HK, et al. Among authors: marks kr. Drug Alcohol Depend. 2021 Jul 1;224:108742. doi: 10.1016/j.drugalcdep.2021.108742. Epub 2021 May 10. Drug Alcohol Depend. 2021. PMID: 33984669 Free PMC article. No abstract available.
The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices.
HEALing Communities Study Consortium. HEALing Communities Study Consortium. Drug Alcohol Depend. 2020 Dec 1;217:108335. doi: 10.1016/j.drugalcdep.2020.108335. Epub 2020 Oct 17. Drug Alcohol Depend. 2020. PMID: 33248391 Free PMC article.
39 results